Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: Impact of constant light-induced nocturnal melatonin suppression

Breast Cancer Research and Treatment

Volumn 79, Issue 3, 2003, Pages 313-320

  Blask, David E ^a   Dauchy, Robert T ^a   Sauer, Leonard A ^a   Krause, Jean A ^a   Brainard, George C ^b  

^a BASSETT RESEARCH INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Circadian disruption; Constant light; Fatty acids; MCF 7 human breast cancer xenografts; Melatonin; Pineal gland

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; FATTY ACID; LINOLEIC ACID; MELATONIN; MITOGENIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOGENESIS; CANCER GROWTH; CELL STRAIN MCF 7; CIRCADIAN RHYTHM; CONTROLLED STUDY; FATTY ACID METABOLISM; HUMAN; HUMAN CELL; LIGHT; LIGHT EXPOSURE; NIGHT; PRIORITY JOURNAL; RAT STRAIN; RISK FACTOR; TUMOR XENOGRAFT;

NON-PROGRAMMATIC;

ANIMALS; ANTIOXIDANTS; ANTITHROMBINS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CIRCADIAN RHYTHM; FEMALE; HUMANS; LIGHT; LINOLEIC ACID; LINOLEIC ACIDS; MELATONIN; MICE; MICE, NUDE; PINEAL GLAND; TRANSPLANTATION, HETEROLOGOUS;

EID: 0037561598     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024030518065     Document Type: Article

References (39)

1. Reiter RJ: Melatonin: a multifaceted messenger to the masses. Lab Med 25: 438-441, 1994.
2. Cassone VM: The pineal gland influences rat circadian activity rhythms in constant light. J Biol Rhythms 7: 27-40, 1992
3. Brainard GC, Richardson BA, King TS, Reiter RJ: The influence of different light spectra on the suppression of pineal melatonin content in the Syrian hamster. Brain Res 294: 333-339, 1984
4. Brainard GC, Richardson BA, King TS, Matthews SA, Reiter RJ: The suppression of pineal melatonin content and N-acetyltransferase activity by different light irradiances in the Syrian hamster: a dose-response relationship. Endocrinology 113: 293-296, 1983
5. Minneman KP, Lynch H, Wurtman: Relationship between environmental light intensity and retina-mediated suppression of rat pineal serotonin-N-acetyltransferase. Life Sci 15: 1791-1796, 1974
6. Reiter RJ, Hurlbut EC, Brainard GC, Steinlechner S, Richardson BA: Influence of light irradiance on hydroxyindole-O-methyltransferase activity, serotonin-N-acetyltransferase activity, and radioimmunoassayable melatonin levels in the pineal gland of the diurnally active Richardson's Ground Squirrel. Brain Res 288: 151-157, 1983
7. Blask DE: An overview of the neuroendocrine regulation of experimental tumor growth by melatonin and its analogues and the therapeutic use of melatonin in oncology. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke D (eds) The Pineal Gland and Cancer. Springer, Berlin, 2001, pp 309-342
8. Blask DE, Sauer LA, Dauchy RT: Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2:113-132, 2002
9. Hill SM, Keifer T, Teplitzky S, Spriggs LL, Ram P: Modulation of the estrogen response pathway in human breast cancer cells by melatonin. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke D (eds) The Pineal Gland and Cancer. Springer, Berlin, 2001, pp 343-358
10. Jöchle W: Trends in photophysiologic concepts. Ann NY Acad Sci 117: 88-104, 1964
11. Kothari L, Shah PN, Mhatre MC: Pineal ablation in varying photoperiods and the incidence of 9,10-dimethyl-1, 2-benzanthracene-induced mammary cancer in rats. Cancer Lett 22: 99-102, 1984
12. Kothari L: Influence of chronic melatonin on 9,10-dimethyl-1, 2-benzanthracene-induced mammary tumors in female Holtzman rats exposed to continuous light. Oncology 44: 64-66, 1987
13. Anderson LE, Morris JE, Sasser LB, Stevens RG: Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett 148: 121-126, 2000
14. Stevens RG: Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125: 556-561, 1987
15. Hansen J: Increased breast cancer risk among women who work predominantly at night. Epidemiology 12: 74-77, 2001
16. Davis S, Mirick DK, Stevens RG: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93: 1557-1562, 2001
17. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA: Rotating night shifts and risk of breast cancer in women participating in the nurse's health study. J Natl Cancer Inst 93: 1563-1568, 2001
18. Hahn RA: Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2: 208-210, 1991
19. Feychting M, Österland B, Ahlbom A: Reduced cancer incidence among the blind. Epidemiology 9: 490-494, 1998
20. Verkasalo P, Pukkala E, Stevens RG, Ojama, Rudanko S-L: Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes and Control 10: 13-20, 1999
21. Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R: Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metabiol 82: 3763-3770, 1997
22. Stevens RG, Rea MS: Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12: 279-287, 2001
23. Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS: Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res 59: 4693-470, 1999
24. Dauchy RT, Blask DE, Sauer LA, Vaughan GM: Light contamination during the dark phase in 'photoperiodically-controlled' animal rooms: effect on tumor growth and metabolism in rats. Lab Anim Sci 47: 511-518, 1997
25. Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA: Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144: 131-136, 1999
26. Folch JM, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-507, 1957
27. McDonald-Gibson RG: Quantitative measurements of arachidonic acid in tissues or fluids. In: Benedetto C, McDonald-Gibson RG, Nigam S, Slater TF (eds) Prostaglandins and Related Substances. IRL Press, Washington, pp 259-268, 1987
28. Tamarkin L, Danforth D, Lichter E, DeMoss M, Cohen M, Chabner B, Lippman M: Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 216: 1003-1005, 1983
29. Hayashi K, Okatani Y: Mechanisms underlying the effects of estrogen on nocturnal melatonin synthesis in peripubertal female rats: relation to norepinephrine and adenylate cyclase. J Pineal Res 26: 178-183, 1999
30. Osborne CK, Hobbs K, Clark GM: Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584-590, 1985
31. Ram PT, Yuan L, Dai J, Kiefer T, Klotz DM, Spriggs LL, Hill SM: Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin. J Pineal Res 28: 210-218, 2000
32. Liu X-H, Connolly JM, Rose DP: The 12-lipoxygenase gene-transfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and omega-6 fatty acid-stimulated proliferation in vitro, and enhanced growth in athymic nude mice. Cancer Lett 109: 223-230, 1996
33. Reiter RJ: The pineal gland, melatonin and reproduction. In: Bittar EE, Bittar N (eds) Principles of Medical Biology. Vol 12, JAI Press, Greenwich, 1998, pp 141-154
34. Mhatre MC, Shah PN, Juneja HS: Effect of varying photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats. J Natl Cancer Inst 72: 141-1415, 1984
35. Shah PN, Mhatre MC, Kothari LS: Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 44: 3403-3407, 1984
36. Seshadri R, Subramanian A, Kothari LS: Effect of neonatal pineal ablation on estradiol receptors in mammary glands of rats housed under varying photoperiods. Indian J Exp Biol 30: 162-164, 1992
37. Graham GC, Cook MR, Gerkovich MM, Sastre A: Examination of the melatonin hypothesis in women exposed at night to EMF or bright light. Environ Health Perspect 109: 501-507, 2001
38. Depres-Bummer P, Levi F, Metzger G, Touitou Y: Light-induced suppression of the rat circadian system. Am J Physiol 268: R1111-R1116, 1995
39. Dillon DC, Easley SE, Asch BB, Cheney RT, Brydon L, Jockers R, Winston JS, Brooks JS, Hurd T, Asch HL: Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 118: 451-458, 2002